Left Ventricular End-Diastolic Diameter Is an Independent Predictor of Mortality in Hemodialysis Patients

Therapeutic Apheresis and Dialysis

Volumn 16, Issue 2, 2012, Pages 134-141

  Inoue, Tomoko ^a   Ogawa, Tetsuya ^b   Iwabuchi, Yuko ^a   Otsuka, Kuniaki ^b   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Echocardiography; Hemodialysis; Left ventricular dilatation; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

ADULT; AGED; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VENTRICLES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84859157300     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.01048.x     Document Type: Article

References (37)

1. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-15.
2. Cheung AK, Sarnak MJ, Yan G etal. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-62.
3. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005;45:S1-153.
4. London GM, Pannier B, Guerin AP etal. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001;12:2759-67.
5. Harnett JD, Foley RN, Kent GM etal. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995;47:884-90.
6. Aoki J, Ikari Y, Nakajima H etal. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 2005;67:333-40.
7. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002;17(Suppl 1):29-36.
8. Schiller NB, Shah PM, Crawford M etal. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
9. Otterstad JE, Froeland G, St John Sutton M. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997;18:507-13.
10. Devereux RB, Alonso DR, Lutas EM etal. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
11. Liao Y, Cooper RS, Durazo-Arvizu R etal. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997;29:641-7.
12. Sahan DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
13. Lang RM, Bierig M, Devereux RB etal. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjuction with the European Association Of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
14. Oki T, Tabata T, Yamada H etal. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997;79:921-8.
15. Fujiu A, Ogawa T, Matsuda N etal. Aortic arch calcification and arterial stiffness are independent factors for diastolic left ventricular dysfunction in chronic hemodialysis patients. Circ J 2008;72:1768-72.
16. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997;30:8-18.
17. Sohn DW, Chai IH, Lee DJ etal. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80.
18. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diastolic cardiomyopathy (the Framingham heart study). Am J Cardiol 1991;68:85-9.
19. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10.
20. Zaslavsky LM, Pinotti AF, Gross JL. Diastolic dysfunction and mortality in diabetic patients on hemodialysis: a 4.25-year controlled prospective study. J Diabetes Complications 2005;19:194-200.
21. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000;11:912-6.
22. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996;27:347-54.
23. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998;54:1720-5.
24. Foley RN, Parfrey PS, Harnett JD etal. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-92.
25. Mimura I, Nishi H, Mise N, Mori M, Sugimoto T. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses. Nephrology 2010;15:549-54.
26. Kunz K, Dimiyrov Y, Muller S, Chantrel F, Thierry H. Uraemic cardiomyopathy. Nephrol Dial Transplant 1998;13(Suppl 4):39-43.
27. Huwez FU, Pringle SD, Macfarlane PW. A new classification of left ventricular geometry in patients with cardiac disease based on M-mode echocardiography. Am J Cardiol 1992;70:681-8.
28. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009;4:S79-91.
29. London GM, Fabiani F, Marchais SJ etal. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 1987;31:973-80.
30. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens 2006;24:1173-80.
31. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 2007;18:1316-22.
32. Kalantar-Zadeh K, Regidor DL, Kovesdy CP etal. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119:671-8.
33. Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ. Serial echographic changes in patients on hemodialysis: an evaluation of guideline implementation. J Nephrol 2006;19:783-93.
34. Shoji T, Shinohara K, Kimoto E etal. Lower risk for cardiovascular mortality in oral 1-hydroxy vitamin D3 users in a haemodilysis population. Nephrol Dial Transplant 2004;19:179-84.
35. Covic A, Voroneanu L, Goldsmith D. The effect of vitamin D therapy on left ventricular structure and function-are these the underlying explanations for improved CKD patient survival? Nephron Clin Pract 2010;116:c187-95.
36. Wang AY, Sanderson J, Sea M etal. Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis. Am J Cin Nutr 2003;77:834-41.
37. Stenvinkel P, Heimburger O, Paultre F etal. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-911.